Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TENM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBE2W - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RIMS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTCH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1257 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
STYK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDM16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP53AIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR124-2HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MKRN7P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LARGE-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYRM9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C10orf10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL3L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on